Jaguar Health (JAGX) Cost of Revenue (2015 - 2026)

Jaguar Health (JAGX) has reported Cost of Revenue for 12 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 124.85% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.4 million (up 116.52% YoY), while the FY2025 annual figure was $3.8 million, up 93.04% from the prior year.
• Cost of Revenue declined to $1.2 million in Q1 2026 per JAGX's latest filing, from $2.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.2 million in Q4 2025 and bottomed at $345000.0 in Q1 2023.
• Historically, Cost of Revenue has averaged $643705.9 across 5 years, with a median of $515000.0 in 2025.
• Annual changes were most pronounced in 2022 — Cost of Revenue plunged 31.33% — and 2025, when it jumped 294.97%.
• Jaguar Health's Cost of Revenue stood at $495000.0 in 2022, then soared by 38.79% to $687000.0 in 2023, then fell by 18.92% to $557000.0 in 2024, then surged by 294.97% to $2.2 million in 2025, then plunged by 47.36% to $1.2 million in 2026.
• Business Quant data shows JAGX's Cost of Revenue at $1.2 million in Q1 2026, $2.2 million in Q4 2025, and $532000.0 in Q3 2025.